Name

Russo Partners

Legal name

Russo Partners LLC

Website

https://russopartnersllc.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

New City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Infrastructure, Others

Revenue model

1. Investor Relations Services: Monthly retainer-based investor relations services, as evidenced by NurExone Biologic engagement at $15,000 per month, subject to TSX Venture Exchange approval
2. Strategic Communications Services: Comprehensive communications services including media relations, corporate communications, thought leadership, and digital/social media management for life sciences companies

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Russo Partners is a strategic healthcare communications firm that provides life sciences companies with integrated public relations, investor relations, corporate communications, digital and social media, thought leadership, and sports-health alliance services on a retainer basis. The firm combines Ph.D. scientists, M.D.s, seasoned journalists, investor relations experts, and digital strategists to translate complex scientific and clinical narratives into media coverage, investor engagement, and stakeholder communications for biopharma, medtech, digital health, diagnostics, healthcare IT, and healthcare services clients globally.

Product overview

Russo Partners is a strategic healthcare communications firm offering integrated PR and investor relations services to life sciences companies. The firm operates as a unified communications engine with six core service lines: Media Relations, Corporate Communications, Investor Relations, Sports-Health Alliance, Digital & Social Media, and Thought Leadership. These services are delivered through multiple sub-services and modules including strategic counsel, crisis management, event management, media training, digital content production, video, website development, earnings calls, investor materials, webinars, and the Russo Edge Podcast. The offering is structured as a service-based consultancy rather than a software product platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Media Relations Building relationships with journalists of influence to enhance visibility across national, industry, business, and local media outlets; for life sciences companies seeking earned media coverage.
• Corporate Communications Creating cohesive messaging strategies for companies, including announcements, crisis management, event assistance, event management, newsletters, messaging and positioning (MAP), and strategic counsel; for life sciences companies.
• Investor Relations Fostering communication between a company and its investors and stakeholders, integrating finance, communications, marketing, and compliance to strengthen investor confidence; for life sciences companies including IPOs, DPOs, SPACs, M&A, and capital-raising activities.
• Sports-Health Alliance Engaging athletes and clinicians to spotlight healthcare causes and products through sports media including Super Bowl Radio Row projects; for healthcare companies seeking distinctive athlete-driven visibility.
• Digital & Social Media Managing corporate social media channels and digital presence across LinkedIn, X, YouTube, and Facebook, including digital branding, paid media, video production, and website development; for life sciences companies engaging digital audiences.
• Thought Leadership Elevating executives through targeted visibility opportunities including awards, bylined articles, op-eds, executive presence, panels, and webinars; for life sciences executives and companies.
• Russo Edge Podcast Conversations with healthcare leaders, scientists, and innovators at the intersection of biotech, healthcare, and innovation; serves as a thought leadership content vehicle for the firm and its clients.

Quantifiable outcome

• Over 150 national and local media segments driven in sports-health campaigns
• +5 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Solomon WilcotscoreGTM or Marketing PartnerSolomon Wilcots, former NFL player for the Cincinnati Bengals and current radio host of 'The Opening Drive' on SiriusXM, collaborates with Russo Partners to strategize media opportunities with professional athlete and physician spokespeople. He hosts the Russo Edge Podcast featuring healthcare leaders and innovators.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• LifeSci Communications: Healthcare and life sciences PR and communications agency serving emerging biotech, pharma, and medtech companies, overlapping heavily with Russo Partners' core client base and service mix.
• Canale Communications: Specialist life sciences PR and communications firm serving biotech, pharma, and digital health clients with media relations and corporate communications - direct competitor in the same vertical.
• 6 Degrees PR: Boutique integrated communications agency focused on health, pharma, and biotech clients, comparable in size, vertical focus, and service breadth to Russo Partners.
• Real Chemistry (formerly W2O Group): Independent healthcare and life sciences communications and data analytics firm serving biopharma and medtech clients with integrated PR, IR, and digital services - the most direct comparable to Russo Partners in healthcare specialty PR.
• ICR (Investor Relations & Communications): Publicly recognized healthcare and technology-focused IR and PR advisory that serves many of the same biotech, medtech, and growth-company clients Russo targets, with overlapping IR retainer offerings.
• Tiberend Strategic Advisors: Healthcare and life sciences strategic communications and investor relations firm serving biotech and pharma clients, with comparable retainer model and life sciences specialization.
• Lazar Partners: Healthcare-focused PR and investor relations firm serving biopharmaceutical and medical device companies with media relations, IR, and strategic communications.
• Westwicke Partners: Boutique IR and strategic communications firm focused exclusively on healthcare, including biotech, medtech, and life sciences - closely comparable niche and retainer model.

Broad incumbents

• Edelman: Largest global PR firm with a dedicated health practice serving pharma, biotech, medtech, and consumer health clients; a broad incumbent competing across most of Russo's service categories.
• Ogilvy Health: Global healthcare marketing and communications network within WPP, serving large pharmaceutical and life sciences brands - competes for enterprise-tier healthcare communications work at far greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/russopartners
• YouTubeyoutube.com/@russopartnersllc
• LinkedInlinkedin.com/company/russo-partners-llc
• Facebookfacebook.com/RussoPartners

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Russo Partners